| Azza Home Health Care Agency | |
| 6501 Nicole Way, Arlington, Texas 76002 | |
| (817) 467-2910 | |
| Name | Azza Home Health Care Agency |
|---|---|
| Location | 6501 Nicole Way, Arlington, Texas |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 743126 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 75050, 75051, 75054, 75070, 75110, 75115, 75134, 75146, 75204, 75212, 75215, 75216, 75224, 75232, 75236, 75237, 75241, 75243, 76002, 76006, 76011, 76013, 76014, 76021, 76028, 76060, 76103, 76105, 76106, 76107, 76110, 76111, 76116, 76118, 76119, 76120, 76123, 76133, 76134, 76137 |
| NPI Number | 1174690143 |
| Organization Name | AZZA PROVIDER SERVICES INC |
| Doing Business As | AZZA HOME HEALTHCARE AGENCY |
| Address | 6501 Nicole Way, Arlington, TX 76002 |
| Phone Number | 817-703-8652 |
News Archive
Texas A&M University System scientists from the departments of nutrition and food science and poultry science have developed a new medium for the cultivation of beneficial microorganisms called lactobacilli.
More than half a million children are diagnosed with swallowing problems each year. The gold standard for diagnosing swallowing problems is the videofluoroscopic swallow study, also known as the modified barium swallow study.
Dicerna Pharmaceuticals, Inc. a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology and Dicer Substrate siRNA (DsiRNA) molecules, today announced a second closing of its Series B equity financing, securing an additional $4 million and bringing the total capital raised in this round to $29 million.
For starters, reports say the proposed rule for the measure's health exchanges is due out July 7. In addition, indications are that many public health provisions remain unfunded and movement toward electronic health records is still slow.
› Verified 1 days ago
| Quality Rating: |
News Archive
Texas A&M University System scientists from the departments of nutrition and food science and poultry science have developed a new medium for the cultivation of beneficial microorganisms called lactobacilli.
More than half a million children are diagnosed with swallowing problems each year. The gold standard for diagnosing swallowing problems is the videofluoroscopic swallow study, also known as the modified barium swallow study.
Dicerna Pharmaceuticals, Inc. a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology and Dicer Substrate siRNA (DsiRNA) molecules, today announced a second closing of its Series B equity financing, securing an additional $4 million and bringing the total capital raised in this round to $29 million.
For starters, reports say the proposed rule for the measure's health exchanges is due out July 7. In addition, indications are that many public health provisions remain unfunded and movement toward electronic health records is still slow.
› Verified 1 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 67.5 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 98.8 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 70 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 83.9 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 86.2 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 86.7 | 96.4 |
News Archive
Texas A&M University System scientists from the departments of nutrition and food science and poultry science have developed a new medium for the cultivation of beneficial microorganisms called lactobacilli.
More than half a million children are diagnosed with swallowing problems each year. The gold standard for diagnosing swallowing problems is the videofluoroscopic swallow study, also known as the modified barium swallow study.
Dicerna Pharmaceuticals, Inc. a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology and Dicer Substrate siRNA (DsiRNA) molecules, today announced a second closing of its Series B equity financing, securing an additional $4 million and bringing the total capital raised in this round to $29 million.
For starters, reports say the proposed rule for the measure's health exchanges is due out July 7. In addition, indications are that many public health provisions remain unfunded and movement toward electronic health records is still slow.
› Verified 1 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 38.8 | 79.6 |
| How often patients got better at getting in and out of bed | 39.4 | 81.1 |
| How often patients got better at bathing | 40.2 | 82.3 |
| How often patients’ breathing improved | 24.9 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 26.9 | 75 |
| How often home health patients had to be admitted to the hospital | - | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | - | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 92.5 | 94 |
News Archive
Texas A&M University System scientists from the departments of nutrition and food science and poultry science have developed a new medium for the cultivation of beneficial microorganisms called lactobacilli.
More than half a million children are diagnosed with swallowing problems each year. The gold standard for diagnosing swallowing problems is the videofluoroscopic swallow study, also known as the modified barium swallow study.
Dicerna Pharmaceuticals, Inc. a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology and Dicer Substrate siRNA (DsiRNA) molecules, today announced a second closing of its Series B equity financing, securing an additional $4 million and bringing the total capital raised in this round to $29 million.
For starters, reports say the proposed rule for the measure's health exchanges is due out July 7. In addition, indications are that many public health provisions remain unfunded and movement toward electronic health records is still slow.
› Verified 1 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
Texas A&M University System scientists from the departments of nutrition and food science and poultry science have developed a new medium for the cultivation of beneficial microorganisms called lactobacilli.
More than half a million children are diagnosed with swallowing problems each year. The gold standard for diagnosing swallowing problems is the videofluoroscopic swallow study, also known as the modified barium swallow study.
Dicerna Pharmaceuticals, Inc. a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology and Dicer Substrate siRNA (DsiRNA) molecules, today announced a second closing of its Series B equity financing, securing an additional $4 million and bringing the total capital raised in this round to $29 million.
For starters, reports say the proposed rule for the measure's health exchanges is due out July 7. In addition, indications are that many public health provisions remain unfunded and movement toward electronic health records is still slow.
› Verified 1 days ago
The patient survey data of Azza Home Health Care Agency is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 92 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 88 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 81 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 87 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 96 | 78 |
News Archive
Texas A&M University System scientists from the departments of nutrition and food science and poultry science have developed a new medium for the cultivation of beneficial microorganisms called lactobacilli.
More than half a million children are diagnosed with swallowing problems each year. The gold standard for diagnosing swallowing problems is the videofluoroscopic swallow study, also known as the modified barium swallow study.
Dicerna Pharmaceuticals, Inc. a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology and Dicer Substrate siRNA (DsiRNA) molecules, today announced a second closing of its Series B equity financing, securing an additional $4 million and bringing the total capital raised in this round to $29 million.
For starters, reports say the proposed rule for the measure's health exchanges is due out July 7. In addition, indications are that many public health provisions remain unfunded and movement toward electronic health records is still slow.
› Verified 1 days ago
Abundant Home Health Llc Location: 1201 N. Watson Road Suite 130, Arlington, Texas 76006 Ratings: Phone: (817) 633-3152 | |
Dfw Home Health Arlington Location: 2225 E Randol Mill Road Suite 400, Arlington, Texas 76011 Ratings: Phone: (817) 633-2273 | |
Alfred Healthcare Services Inc. Location: 1601 E Lamar Blvd Suite 117, Arlington, Texas 76011 Ratings: Phone: (817) 548-8500 | |
Prudential Health Care Services Inc Location: 351 W Randol Mill Road, Arlington, Texas 76011 Ratings: NA Phone: (817) 608-0455 | |
All Care Professional Home Health Inc Location: 4275 Little Road, Suite 106, Arlington, Texas 76016 Ratings: Phone: (817) 457-2688 | |
Rosas First Quality Home Healthcare Llc Location: 306 East Randol Mill Road Suite 100, Arlington, Texas 76011 Ratings: Phone: (817) 461-0154 |